¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, ¿ëµµº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
U.S. Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1493321
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 36¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß CAGRÀº 5.5%·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀº ¹é½Å ¼ö¿ä Áõ°¡, ¾à¹° ÀÚ°¡ Åõ¾à Áõ°¡, ¾ÈÀü ÁÖ»ç±â äÅà Ȯ´ë, ±â¼ú ¹ßÀüÀÌ ¹Ì±¹ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

SARS-CoV-2 ÆÒµ¥¹ÍÀº º´¿ø¿ëǰ, ±¸±Þ¿ëǰ, ÀÇ·á ¼Ò¸ðǰ, ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×À¸¸ç, COVID-19ÀÇ ¿µÇâÀ¸·Î COVID-19 ¹é½Å »ý»êÀÌ Áõ°¡ÇÏ¿© ¹Ì±¹»ê ÀÏȸ¿ë ÁÖ»ç±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­¸¸ ¹é½Å Á¢Á¾¿¡ 6¾ï 5,000¸¸-8¾ï 5,000¸¸ °³ÀÇ ÁÖ»ç¹Ù´Ã°ú ÁÖ»ç±â°¡ ÇÊ¿äÇÒ °ÍÀ¸·Î Biomedical Advanced Research and Development Authority(BARDA)´Â ¿¹ÃøÇß½À´Ï´Ù. µû¶ó¼­ COVID-19 ÆÒµ¥¹ÍÀº ÀÇ·á¿ë ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ¹Ì±¹ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀÇ ¸Å¿ì È¿°úÀûÀÎ ÃËÁø¿äÀÎÀ¸·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù.

¾ÕÀ¸·Î À¯¿£¾Æµ¿±â±Ý(UNICEF)°ú °°Àº ±â°üÀº 2021³â ¸»±îÁö COVID-19 ½Ã¼³ ±¹°¡ÀÇ COVID-19 ¿¹¹æÁ¢Á¾ Ȱµ¿À» À§ÇØ 10¾ï °³ÀÇ ÁÖ»ç±â¸¦ ±¸ÀÔÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÁÖ»ç±â´Â ¸ðµÎ ¼¼°èº¸°Ç±â±¸(WHO)°¡ Çã¿ëÇÏ´Â ÀÚµ¿ µð¼Åºí(AD) À¯ÇüÀÌ µÉ °ÍÀÔ´Ï´Ù. ±× °á°ú, ½ÃÀå ¼ºÀåÀº °¡±î¿î ¹Ì·¡¿¡ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå º¸°í¼­ - ÁÖ¿ä ³»¿ë

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ºÎ¹® ºÐ¼®, Á¦Ç°º°, 2018-2030³â

Á¦5Àå ¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ºÎ¹® ºÐ¼®, ¿ëµµº°, 2018-2030³â

Á¦6Àå ¹Ì±¹ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå - °æÀï ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Disposable Syringes Market Growth & Trends:

The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

U.S. Disposable Syringes Market Report Highlights:

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Disposable Syringes Market Variables, Trends & Scope

Chapter 4 U.S. Disposable Syringes Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

Chapter 5 U.S. Disposable Syringes Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

Chapter 6 U.S. Disposable Syringes Market - Competitive Analysis

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â